These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2880007)

  • 21. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
    Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
    Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Dorr RT
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):2-5. PubMed ID: 2116668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of total-body irradiation and attempted marrow transplantation in acute leukemia.
    ANDREWS GA; SITTERSON BW; KRETCHMAR AL; TANIDA R
    Acta Haematol; 1961; 26():129-53. PubMed ID: 13861485
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioavailability of orally administered mesna.
    Burkert H; Lücker PW; Wetzelsberger N; Breuel HP
    Arzneimittelforschung; 1984; 34(11):1597-600. PubMed ID: 6441581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total body irradiation preceding bone marrow transplantation.
    Lancet; 1983 Apr; 1(8328):803-4. PubMed ID: 6132139
    [No Abstract]   [Full Text] [Related]  

  • 26. [Total body irradiation in the preparation of leukemic patients for bone marrow transplantation].
    Vitale V; Scielzo G; Ricci G; Bacigalupo A; Tomassini E; Marziano C; Siragusa A; Van Lint MT; Bistolfi F
    Radiol Med; 1983; 69(1-2):29-36. PubMed ID: 6338567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose ifosfamide with mesna uroprotection: a phase I study.
    Elias AD; Eder JP; Shea T; Begg CB; Frei E; Antman KH
    J Clin Oncol; 1990 Jan; 8(1):170-8. PubMed ID: 2104923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Pratt CB; Douglass EC; Etcubanas E; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):51-5. PubMed ID: 2495567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
    Tutschka PJ; Copelan EA; Kapoor N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2952-4. PubMed ID: 2650402
    [No Abstract]   [Full Text] [Related]  

  • 30. [Improvement in a total body irradiation technic as a preparation for bone marrow transplantation in leukemia].
    Inoue T; Chatani M; Teshima T; Hata K; Izawa K; Sasaki J; Kawanabe K
    Rinsho Hoshasen; 1987 Apr; 32(4):557-60. PubMed ID: 3302420
    [No Abstract]   [Full Text] [Related]  

  • 31. Mistabron in the intensive care unit.
    Van De Walle J; Lauwers P; Adriaensen H
    Acta Anaesthesiol Belg; 1976; 27 suppl():319-21. PubMed ID: 827913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ifosfamide/mesa and encephalopathy.
    Cantwell BM; Harris AL
    Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
    James CA; Mant TG; Rogers HJ
    Br J Clin Pharmacol; 1987 May; 23(5):561-8. PubMed ID: 3109461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Whole body irradiation before bone marrow transplantation in malignant systemic diseases].
    Schwarz R; Hornung D; Hübener KH
    Rontgenpraxis; 1988 Sep; 41(9):319-23. PubMed ID: 3055345
    [No Abstract]   [Full Text] [Related]  

  • 36. [Uroprotection with mesna in the chemotherapy of malignant tumors with oxazaphosphorines. Biometric evaluation of a sequential clinical study].
    Schnitker J
    Arzneimittelforschung; 1982; 32(10):1334-8. PubMed ID: 6817761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies on the mucolytic effect of mesna.
    Tekeres M; Horváth A; Bárdosi L; Kenyeres P
    Clin Ther; 1981; 4(1):56-60. PubMed ID: 6791825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False positive reaction for urinary ketones with mesna.
    Ben Yehuda A; Heyman A; Steiner-Salz D
    Drug Intell Clin Pharm; 1987 Jun; 21(6):547-8. PubMed ID: 3111808
    [No Abstract]   [Full Text] [Related]  

  • 39. WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
    Souid AK; Fahey RC; Dubowy RL; Newton GL; Bernstein ML
    Cancer Chemother Pharmacol; 1999; 44(6):498-504. PubMed ID: 10550571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the radioprotective effect of etiocholanolone.
    Ambrus JL; Ambrus CM; Gahwyler ME; Akhter S; Jankowski A; Lane W
    J Med; 2004; 35(1-6):75-86. PubMed ID: 18084866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.